Source: Laboratory investigation. Conference titles: Annual Meeting of the United States and Canadian Academy of Pathology. Unidade: FM
Subjects: PROGNÓSTICO, FÁRMACOS IMUNOSSUPRESSORES, BIOMARCADORES, RESUMOS (EVENTOS)
ABNT
PAULA, Henrique de et al. 5 Diffuse Large B-Cell Lymphoma, NOS: Prognostic Significance of Immunohistochemical Algorithms and Biomarkers in Newly Diagnosed Patients Treated With Rituximab Plus a CHOP-Like Regimen. Laboratory investigation. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.nature.com/labinvest/journal/v95/n1s/pdf/labinvest201512a.pdf. Acesso em: 10 nov. 2024. , 2015APA
Paula, H. de, Siqueira, S., Pereira, J., Lage, L. A., Xavier, F., Costa, R., & Zerbini, M. C. (2015). 5 Diffuse Large B-Cell Lymphoma, NOS: Prognostic Significance of Immunohistochemical Algorithms and Biomarkers in Newly Diagnosed Patients Treated With Rituximab Plus a CHOP-Like Regimen. Laboratory investigation. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.nature.com/labinvest/journal/v95/n1s/pdf/labinvest201512a.pdfNLM
Paula H de, Siqueira S, Pereira J, Lage LA, Xavier F, Costa R, Zerbini MC. 5 Diffuse Large B-Cell Lymphoma, NOS: Prognostic Significance of Immunohistochemical Algorithms and Biomarkers in Newly Diagnosed Patients Treated With Rituximab Plus a CHOP-Like Regimen [Internet]. Laboratory investigation. 2015 ; 95 341A.[citado 2024 nov. 10 ] Available from: http://www.nature.com/labinvest/journal/v95/n1s/pdf/labinvest201512a.pdfVancouver
Paula H de, Siqueira S, Pereira J, Lage LA, Xavier F, Costa R, Zerbini MC. 5 Diffuse Large B-Cell Lymphoma, NOS: Prognostic Significance of Immunohistochemical Algorithms and Biomarkers in Newly Diagnosed Patients Treated With Rituximab Plus a CHOP-Like Regimen [Internet]. Laboratory investigation. 2015 ; 95 341A.[citado 2024 nov. 10 ] Available from: http://www.nature.com/labinvest/journal/v95/n1s/pdf/labinvest201512a.pdf